This article examines the European Commission’s Draft Merger Guidelines, published for consultation on 30 April 2026, and their extension of merger control from specific innovation competition — rivalry around identifiable products or R&D projects — to general innovation competition among firms whose capabilities may yield products that cannot yet be identified. The author isolates two prior questions on which the new theory of harm depends: what it seeks to protect (the distribution o
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 216.73.217.78
Please verify email or join us to access premium content!